328 related articles for article (PubMed ID: 32183837)
1. Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
Altmann P; De Simoni D; Kaider A; Ludwig B; Rath J; Leutmezer F; Zimprich F; Hoeftberger R; Lunn MP; Heslegrave A; Berger T; Zetterberg H; Rommer PS
J Neuroinflammation; 2020 Mar; 17(1):86. PubMed ID: 32183837
[TBL] [Abstract][Full Text] [Related]
2. Ratio and index of Neurofilament light chain indicate its origin in Guillain-Barré Syndrome.
Körtvelyessy P; Kuhle J; Düzel E; Vielhaber S; Schmidt C; Heinius A; Leypoldt F; Schraven B; Reinhold D; Leppert D; Goihl A
Ann Clin Transl Neurol; 2020 Nov; 7(11):2213-2220. PubMed ID: 33030817
[TBL] [Abstract][Full Text] [Related]
3. Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients.
Martín-Aguilar L; Camps-Renom P; Lleixà C; Pascual-Goñi E; Díaz-Manera J; Rojas-García R; De Luna N; Gallardo E; Cortés-Vicente E; Muñoz L; Alcolea D; Lleó A; Casasnovas C; Homedes C; Gutiérrez-Gutiérrez G; Jimeno-Montero MC; Berciano J; Sedano-Tous MJ; García-Sobrino T; Pardo-Fernández J; Márquez-Infante C; Rojas-Marcos I; Jericó-Pascual I; Martínez-Hernández E; Morís de la Tassa G; Domínguez-González C; Illa I; Querol L
J Neurol Neurosurg Psychiatry; 2020 Nov; ():. PubMed ID: 33154183
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.
Axelsson M; Sjögren M; Andersen O; Blennow K; Zetterberg H; Lycke J
Acta Neurol Scand; 2018 Aug; 138(2):143-150. PubMed ID: 29624650
[TBL] [Abstract][Full Text] [Related]
5. Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke.
Wang P; Fan J; Yuan L; Nan Y; Nan S
Neurotox Res; 2020 Apr; 37(4):987-995. PubMed ID: 31898161
[TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.
Siller N; Kuhle J; Muthuraman M; Barro C; Uphaus T; Groppa S; Kappos L; Zipp F; Bittner S
Mult Scler; 2019 Apr; 25(5):678-686. PubMed ID: 29542376
[TBL] [Abstract][Full Text] [Related]
7. Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.
Onatsu J; Vanninen R; Jäkälä P; Mustonen P; Pulkki K; Korhonen M; Hedman M; Zetterberg H; Blennow K; Höglund K; Herukka SK; Taina M
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2242-2249. PubMed ID: 31151840
[TBL] [Abstract][Full Text] [Related]
8. CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome.
Petzold A; Brettschneider J; Jin K; Keir G; Murray NM; Hirsch NP; Itoyama Y; Reilly MM; Takeda A; Tumani H
Muscle Nerve; 2009 Jul; 40(1):42-9. PubMed ID: 19533642
[TBL] [Abstract][Full Text] [Related]
9. Elevated blood and cerebrospinal fluid glucose levels affect the severity and short-term prognosis of Guillain-Barré syndrome.
Gong Q; Liu S; Xiao Z; Fu X; Lu Z
Neurol Res; 2022 Feb; 44(2):121-127. PubMed ID: 34382919
[TBL] [Abstract][Full Text] [Related]
10. Serum neurofilament light chain in patients with acute cerebrovascular events.
De Marchis GM; Katan M; Barro C; Fladt J; Traenka C; Seiffge DJ; Hert L; Gensicke H; Disanto G; Sutter R; Peters N; Sarikaya H; Goeggel-Simonetti B; El-Koussy M; Engelter S; Lyrer PA; Christ-Crain M; Arnold M; Kuhle J; Bonati LH
Eur J Neurol; 2018 Mar; 25(3):562-568. PubMed ID: 29281157
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neurofilament light chain predicts short-term prognosis in pediatric Guillain-Barré syndrome.
Jin M; Liu K; Zhao L; Liu J; Zhao Z; Zhao Y; Sun S
Front Neurol; 2022; 13():972367. PubMed ID: 36071910
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
Wang XK; Zhang HL; Meng FH; Chang M; Wang YZ; Jin T; Mix E; Zhu J
Neurol Sci; 2013 May; 34(5):655-61. PubMed ID: 22526766
[TBL] [Abstract][Full Text] [Related]
13. Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection.
Traenka C; Disanto G; Seiffge DJ; Gensicke H; Hert L; Grond-Ginsbach C; Peters N; Regeniter A; Kloss M; De Marchis GM; Bonati LH; Lyrer PA; Kuhle J; Engelter ST
Cerebrovasc Dis; 2015; 40(5-6):222-7. PubMed ID: 26418549
[TBL] [Abstract][Full Text] [Related]
14. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.
Uphaus T; Bittner S; Gröschel S; Steffen F; Muthuraman M; Wasser K; Weber-Krüger M; Zipp F; Wachter R; Gröschel K
Stroke; 2019 Nov; 50(11):3077-3084. PubMed ID: 31537188
[TBL] [Abstract][Full Text] [Related]
15. Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction.
Pedersen A; Stanne TM; Nilsson S; Klasson S; Rosengren L; Holmegaard L; Jood K; Blennow K; Zetterberg H; Jern C
J Neurol; 2019 Nov; 266(11):2796-2806. PubMed ID: 31375988
[TBL] [Abstract][Full Text] [Related]
16. Serum Neurofilament Light Chain as a Predictive Biomarker for Ischemic Stroke Outcome: A Systematic Review and Meta-analysis.
Liu D; Chen J; Wang X; Xin J; Cao R; Liu Z
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104813. PubMed ID: 32305278
[TBL] [Abstract][Full Text] [Related]
17. Association of serum biomarker neurofilament light concentration with post-stroke depression: A preliminary study.
Zhao H; Mo M; Miao C; Li L; Yang H; Liu Y; Yang G
Gen Hosp Psychiatry; 2020; 64():17-25. PubMed ID: 32078857
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.
Bittner S; Steffen F; Uphaus T; Muthuraman M; Fleischer V; Salmen A; Luessi F; Berthele A; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Linker R; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kuempfel T; Weber F; Zettl UK; Ziemann U; Tumani H; Groppa S; Mühlau M; Lukas C; Hemmer B; Wiendl H; Gold R; Zipp F;
EBioMedicine; 2020 Jun; 56():102807. PubMed ID: 32460167
[TBL] [Abstract][Full Text] [Related]
19. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
Gaiottino J; Norgren N; Dobson R; Topping J; Nissim A; Malaspina A; Bestwick JP; Monsch AU; Regeniter A; Lindberg RL; Kappos L; Leppert D; Petzold A; Giovannoni G; Kuhle J
PLoS One; 2013; 8(9):e75091. PubMed ID: 24073237
[TBL] [Abstract][Full Text] [Related]
20. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
